ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study

References

• Eisen A. Amyotrophic lateral sclerosis: a 40-year personal perspective. J Clin Neurosci. 2009;16:505–2.
   PubMed Web of Science ®Google Scholar
• Ismail A, Cooper-Knock J, Highley JR, Milano A, Kirby J, Goodall E, et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84:79–87.
   PubMed Web of Science ®Google Scholar
• Cui C, Longinetti E, Larsson H, Andersson J, Pawitan Y, Piehl F, et al. Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study. Amyotroph Lateral Scler Frontotemporal Degener 2020;22(3–4):211–9.
   PubMed Web of Science ®Google Scholar
• Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 2013;81:1222–5.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X, Sundquist J, Sundquist K. Familial risks for amyotrophic lateral sclerosis and autoimmune diseases. Neurogenetics 2009;10:111–6.
   PubMed Web of Science ®Google Scholar
• Etemadifar M, Abtahi SH, Akbari M, Maghzi AH. Multiple sclerosis and amyotrophic lateral sclerosis: is there a link? Mult Scler. 2012;18:902–4.
   PubMed Web of Science ®Google Scholar
• Tai H, Cui L, Guan Y, Liu M, Li X, Huang Y, et al. Amyotrophic lateral sclerosis and myasthenia gravis overlap syndrome: a review of two cases and the associated literature. Front Neurol. 2017;8:218.
   PubMedGoogle Scholar
• Gotaas HT, Skeie GO, Gilhus NE. Myasthenia gravis and amyotrophic lateral sclerosis: a pathogenic overlap. Neuromuscul Disord. 2016;26:337–41.
   PubMed Web of Science ®Google Scholar
• Del Mar Amador M, Vandenberghe N, Berhoune N, Camdessanche JP, Gronier S, Delmont E, et al. Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system? Neuromuscul Disord. 2016;26:342–6.
   PubMed Web of Science ®Google Scholar
• Restivo DA, Bianconi C, Ravenni R, De Grandis D. ALS and myasthenia: an unusual association in a patient treated with riluzole. Muscle Nerve. 2000;23:294–5.
   PubMed Web of Science ®Google Scholar
• de Pasqua S, Cavallieri F, D’Angelo R, Salvi F, Fini N, D’Alessandro R, et al. Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? Neurol Sci. 2017;38:441–4.
   PubMed Web of Science ®Google Scholar
• Naik KR, Saroja AO, Mahajan M. Unusual occurrence of amyotrophic lateral sclerosis in myasthenia gravis. Amyotroph Lateral Scler. 2012;13:477–8.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Fujimoto A, Mori Y, Hirahara T, Mori A, Hirano T, et al. Coexistence of amyotrophic lateral sclerosis and myasthenia gravis. J Neuromuscul Dis. 2014;1:111–5.
   PubMedGoogle Scholar
• Ohnari K, Okada K, Higuchi O, Matsuo H, Adachi H. Late-onset myasthenia gravis accompanied by amyotrophic lateral sclerosis with antibodies against the acetylcholine receptor and low-density lipoprotein receptor-related protein 4. Intern Med. 2018;57:3021–4.
   PubMed Web of Science ®Google Scholar
• Tseng CC, Chang SJ, Tsai WC, Ou TT, Wu CC, Sung WY, et al. Increased incidence of amyotrophic lateral sclerosis in polymyositis: a nationwide cohort study. Arthritis Care Res (Hoboken). 2017;69:1231–7.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–67.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener 2019;20(3–4):133–145.
   PubMed Web of Science ®Google Scholar
• McNicholas N, Hutchinson M, McGuigan C, Chataway J. 2017 McDonald diagnostic criteria: a review of the evidence. Mult Scler Relat Disord. 2018;24:48–54.
   PubMed Web of Science ®Google Scholar
• Huijbers MG, Niks EH, Klooster R, de Visser M, Kuks JB, Veldink JH, et al. Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis. Neuromuscul Disord. 2016;26:350–3.
   PubMed Web of Science ®Google Scholar
• Okuyama Y, Mizuno T, Inoue H, Kimoto K. Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody. Intern Med. 1997;36:312–5.
   PubMed Web of Science ®Google Scholar
• Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010;17:356–63.
   PubMed Web of Science ®Google Scholar
• European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society–first revision. J Peripher Nerv Syst 2010;15:295–301.
   PubMedGoogle Scholar
• Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol. 1981;9:1–5.
   PubMed Web of Science ®Google Scholar
• Longinetti ER, Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi LO, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(7–8):528–37.
   PubMed Web of Science ®Google Scholar
• Shellikeri S, Karthikeyan V, Martino R, Black SE, Zinman L, Keith J, et al. The neuropathological signature of bulbar-onset ALS: a systematic review. Neurosci Biobehav Rev. 2017;75:378–92.
   PubMed Web of Science ®Google Scholar
• Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2005;32:808–11.
   PubMed Web of Science ®Google Scholar
• Simonds AK. Home ventilation. Eur Respir J Suppl. 2003;47:38s–46s.
   PubMedGoogle Scholar
• Nygren I, Antonova K, Mattsson P, Askmark H. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics. Acta Neurol Scand. 2005;111:180–4.
   PubMed Web of Science ®Google Scholar
• Smeltzer JS. The effects of liability fears. N Engl J Med. 1989;320:1221.
   PubMed Web of Science ®Google Scholar
• Javidi E, Magnus T. Autoimmunity after ischemic stroke and brain injury. Front Immunol 2019;10:686.
   PubMed Web of Science ®Google Scholar
• Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81:718–28.
   PubMed Web of Science ®Google Scholar
• Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23:1916–22.
   PubMed Web of Science ®Google Scholar